PubRank

A S ALVING

Author PubWeight™ 67.21‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Enzymatic deficiency in primaquine-sensitive erythrocytes. Science 1956 5.39
2 The hemolytic effect of primaquine. VII. Biochemical studies of drug-sensitive erythrocytes. J Lab Clin Med 1955 2.63
3 Primaquine sensitivity. Glucose-6-phosphate dehydrogenase deficiency: an inborn error of metabolism of medical and biological significance. Arch Intern Med 1962 2.52
4 Mitigation of the haemolytic effect of primaquine and enhancement of its action against exoerythrocytic forms of the Chesson strain of Piasmodium vivax by intermittent regimens of drug administration: a preliminary report. Bull World Health Organ 1960 2.50
5 Methaemoglobin reduction test: a new, simple, in vitro test for identifying primaquine-sensitivity. Bull World Health Organ 1960 2.28
6 The methemoglobin reduction test for primaquine-type sensitivity of erythrocytes. A simplified procedure for detecting a specific hypersusceptibility to drug hemolysis. JAMA 1962 2.10
7 Primaquine, SN 13272, a new curative agent in vivax malaria; a preliminary report. J Natl Malar Soc 1950 1.79
8 Korean vivax malaria. III. Curative effect and toxicity of primaquine in doses from 10 to 30 mg. daily. Am J Trop Med Hyg 1953 1.79
9 Korean vivax malaria. I. Natural history and response to chloroquine. Am J Trop Med Hyg 1953 1.75
10 Toxicity of primaquine in Caucasians. J Am Med Assoc 1952 1.74
11 Hemolytic effect of therapeutic drugs. Clinical considerations of the primaquine-type hemolysis. JAMA 1962 1.71
12 The hemolytic effect of primaquine. II. The natural course of the hemolytic anemia and the mechanism of its self-limited character. J Lab Clin Med 1954 1.67
13 Korean vivax malaria. V. Cure of the infection by primaquine administered during long-term latency. Am J Trop Med Hyg 1953 1.66
14 Toxicity of primaquine in Negroes. J Am Med Assoc 1952 1.63
15 Potentiation of the curative action of primaquine in vivax malaria by quinine and chloroquine. J Lab Clin Med 1955 1.55
16 The hemolytic effect of primaquine. IV. The relationship of cell age to hemolysis. J Lab Clin Med 1954 1.50
17 STUDIES ON A STRAIN OF CHLOROQUINE-RESISTANT PLASMODIUM FALCIPARUM FROM THAILAND. Bull World Health Organ 1964 1.48
18 The hemolytic effect of primaquine. VI. An in vitro test for sensitivity of erythrocytes to primaquine. J Lab Clin Med 1955 1.37
19 Mass therapy of subclinical vivax malaria with primaquine. J Am Med Assoc 1952 1.35
20 Korean vivax malaria. II. Curative treatment with pamaquine and primaquine. Am J Trop Med Hyg 1953 1.35
21 The hemolytic effect of primaquine. I. The localization of the drug-induced hemolytic defect in primaquine-sensitive individuals. J Lab Clin Med 1954 1.33
22 Biochemical and genetic aspects of primaquine-sensitive hemolytic anemia. Ann Intern Med 1958 1.28
23 Cure of Korean vivax malaria with pamaquine and primaquine. J Am Med Assoc 1952 1.27
24 The antimalarial action of primaquine against the blood and tissue stages of falciparum malaria (Panama, P-F-6 strain). J Lab Clin Med 1955 1.25
25 STUDIES ON A STRAIN OF CHLOROQUINE-RESISTANT PLASMODIUM FALCIPARUM FROM COLOMBIA, SOUTH AMERICA. Am J Trop Med Hyg 1963 1.24
26 The hemolytic effect of primaquine. V. Primaquine sensitivity as a manifestation of a multiple drug sensitivity. J Lab Clin Med 1955 1.23
27 The hemolytic effect of primaquine. III. A study of primaquine-sensitive erythrocytes. J Lab Clin Med 1954 1.22
28 The influence of dietary protein intake on specific renal functions in normal man. J Lab Clin Med 1954 1.21
29 The hemolytic effect of primaquine. VIII. The effect of drug administration on parameters of primaquine sensitivity. J Lab Clin Med 1958 1.12
30 The hemolytic effect of primaquine. XIII. Gradient susceptibility to hemolysis of primaquine-sensitive erythrocytes. J Lab Clin Med 1961 1.09
31 STUDIES ON A STRAIN OF CHLOROQUINE-RESISTANT PLASMODIUM FALCIPARUM FROM VIET-NAM. Bull World Health Organ 1964 1.07
32 The hemolytic effect of primaquine. IX. Enzymatic abnormalities in primaquine-sensitive erythrocytes. J Lab Clin Med 1958 1.06
33 Natural history of Korean vivax malaria after deliberate inoculation of human volunteers. J Lab Clin Med 1954 1.03
34 The Chesson strain of Plasmodium vivax malaria; relationship between prepatent period, latent period and relapse rate. J Infect Dis 1947 1.00
35 A clinical study of primaquine (S. N. 13,272) in the treatment of malaria among the Miskito Indians of Nicaragua. Am J Trop Med Hyg 1953 0.98
36 Induced primaquine resistance in vivax malaria. Trans R Soc Trop Med Hyg 1961 0.95
37 Korean vivax malaria. IV. Curative effect of 15 milligrams of primaquine daily for 7 days. Am J Trop Med Hyg 1953 0.93
38 The effect of continuous and intermittent primaquine therapy on the relapse rate of Chesson strain vivax malaria. J Lab Clin Med 1954 0.92
39 Coenzyme studies in primaquine-sensitive erythrocytes. Proc Soc Exp Biol Med 1958 0.92
40 The hemolytic effect of primaquine. XV. Role of methemoglobin. J Lab Clin Med 1962 0.89
41 HEMOLYTIC EFFECT OF PRIMAQUINE. XVII. HEXOKINASE ACTIVITY OF GLUCOSE-6-PHOSPHATE DEHYDROGENASE-DEFICIENT AND NORMAL ERYTHROCYTES. J Lab Clin Med 1964 0.85
42 Glucose-6-phosphate dehydrogenase deficiency: some biological implications. Trans Assoc Am Physicians 1960 0.85
43 The concurrent weekly administration of chloroquine and primaquine for the prevention of Korean vivax malaria. Bull World Health Organ 1961 0.84
44 Physiological changes during perfusion of the isolated intestinal loop in chronic uremia. J Lab Clin Med 1952 0.81
45 The hemolytic effect of primaquine. X. Aldolase and glyceraldehyde-3-phosphate dehydrogenase activity in primaquine-sensitive erythrocytes. J Lab Clin Med 1959 0.81
46 The hemolytic effect of primaquine. XIV. Pentose metabolism in primaquine-sensitive erythrocytes. J Lab Clin Med 1961 0.81
47 A method of determining the specific renal functions of glomerular filtration, maximal tubular excretion (or reabsorption) and effective blood flow using a single injection of a single substance. J Lab Clin Med 1947 0.78
48 A clinical method of determining the specific renal functions of glomerular filtration, maximal tubular excretion or reabsorption (and effective blood flow) using a single injection of a single substance. Proc Annu Meet Cent Soc Clin Res U S 1945 0.75
49 A review of the best new antimalarial drugs. Whats New 1950 0.75
50 The clinical trial of 18 analogues of pamaquin (plasmochin) in vivax malaria, Chesson strain. J Clin Invest 1948 0.75
51 A study of the prophylactic, curative and suppressive activity of SN-11,437 (metachloridine) in standardized infections of vivax malaria. Am J Trop Med Hyg 1948 0.75
52 Study of pentaquine and isopentaquine, therapeutic agents effective in reducing relapse rate in vivax malaria. Abstr Int Congr Trop Med Malar 1948 0.75
53 Malignant hypertension. Med Clin North Am 1951 0.75
54 Pentaquine (SN-13,276) a therapeutic agent effective in reducing the relapse rate in vivax malaria. J Clin Invest 1948 0.75
55 Toxicity studies of pyrimethamine (daraprim). Am J Trop Med Hyg 1955 0.75
56 Studies on the chronic toxicity of chloroquine (SN-7618). J Clin Invest 1948 0.75
57 Renal resistance in essential hypertension; relation to the effect of sympathectomy on blood pressure. Proc Soc Exp Biol Med 1948 0.75
58 Pentaquine (SN-13,276) a new antimalarial effective in reducing the relapse rate of vivax malaria. Proc Annu Meet Cent Soc Clin Res U S 1947 0.75
59 A clinical method of determining the specific renal functions of glomerular filtration and maximal tubular excretion, or reabsorption (and effective blood flow), using a single injection of a single substance. J Lab Clin Med 1946 0.75
60 HEMOLYTIC EFFECT OF PRIMAQUINE. XVI. GLYOXALASE ACTIVITY OF PRIMAQUINE-SENSITIVE AND NORMAL ERYTHROCYTES. J Lab Clin Med 1964 0.75
61 Alterations of cerebral functions in pheochromocytoma. Neurology 1951 0.75
62 The relation of renal to non-renal vascular resistances in essential hypertension; and the effect of sympathectomy. J Clin Invest 1948 0.75
63 Procedures used at Stateville penitentiary for the testing of potential antimalarial agents. J Clin Invest 1948 0.75